Humoral Immunity Disorders Associated with Antibody Deficit
|
By LabMedica International staff writers Posted on 16 Jul 2018 |

Image: The BN ProSpec chemistry analyzer is a dedicated, compact system that offers a consolidated menu of specialty and routine reagents for reliable plasma protein testing (Photo courtesy of Siemens Healthcare).
Primary Immunodeficiencies (PID) are a heterogeneous group of diseases and they are rare diseases, but not as rare as once thought, with approximately 400 new PID cases are diagnosed annually in the USA.
Most common among PIDs are disorders of the humoral response associated with deficiency of antibodies, a heterogeneous group of proteins present in the body fluids of all vertebrates and characterized by a common pattern of construction. The most important of these are immunoglobulins (Ig) of the IgG class which account for about 75% of all immunoglobulins contained in serums.
Scientists at the Wroclaw Medical University (Wroclaw, Poland) analyzed the structure of patients group according to difference between total IgG and sum of the IgG subclasses and to determine factors affecting the level of this difference. This study was based on data collected from 670 children referred to the Department of Clinical Immunology and Pediatrics in order to diagnose the immune disorders. The median age of patients was 4.2 years with 421 males (62.8%) and 249 females (37.2%).
For all children the levels of the total of immunoglobulins IgG and of the IgG subclasses (IgG1, IgG2, IgG3, and IgG4) were determined. The group of children was divided into subgroups according to gender, age (under 6 years of age, 6.5 to 12 years, and 12 to18 years), and IgG abnormality (below the normal range, normal and above the normal range). The immunoturbidimetric method utilizing the ARCHITECT cSystem was used for total IgG determination. In contrast, IgG subclass levels were measured by the nephelometric method with the use of a BN ProSpec chemistry analyzer.
The scientists found for 80 patients IgG was below the normal range, for 496 patients IgG was normal, and for 73 patients IgG was above the normal range (12.3, 76.5 and 11.2%, respectively). The group of 80 patients with Total IgG deficiency can be divided according to the medical history into three clinical subgroups: recurrent respiratory tract infections (RRT), primary immunodeficiency (PID) and transient hypogammaglobulinemia of infancy (THI). Analyzing IgG abnormality groups, it was concluded that for the population with IgG greater than IgG sum, there is a lower proportion of patients with IgG below normal range than with IgG normal or above normal range.
The authors concluded that determination of serum immunoglobulin levels is an increasingly available and relatively inexpensive laboratory test performed not only in specialized departments but also in primary care. Assessment of IgG levels as well as IgA and IgM is one of the fundamental studies on the function of the immune system. The indications for their markings are very different and primarily include diagnostics for primary and secondary immunodeficiencies. The study was published on June 27, 2018, in the journal BMC Immunology.
Related Links:
Wroclaw Medical University
Most common among PIDs are disorders of the humoral response associated with deficiency of antibodies, a heterogeneous group of proteins present in the body fluids of all vertebrates and characterized by a common pattern of construction. The most important of these are immunoglobulins (Ig) of the IgG class which account for about 75% of all immunoglobulins contained in serums.
Scientists at the Wroclaw Medical University (Wroclaw, Poland) analyzed the structure of patients group according to difference between total IgG and sum of the IgG subclasses and to determine factors affecting the level of this difference. This study was based on data collected from 670 children referred to the Department of Clinical Immunology and Pediatrics in order to diagnose the immune disorders. The median age of patients was 4.2 years with 421 males (62.8%) and 249 females (37.2%).
For all children the levels of the total of immunoglobulins IgG and of the IgG subclasses (IgG1, IgG2, IgG3, and IgG4) were determined. The group of children was divided into subgroups according to gender, age (under 6 years of age, 6.5 to 12 years, and 12 to18 years), and IgG abnormality (below the normal range, normal and above the normal range). The immunoturbidimetric method utilizing the ARCHITECT cSystem was used for total IgG determination. In contrast, IgG subclass levels were measured by the nephelometric method with the use of a BN ProSpec chemistry analyzer.
The scientists found for 80 patients IgG was below the normal range, for 496 patients IgG was normal, and for 73 patients IgG was above the normal range (12.3, 76.5 and 11.2%, respectively). The group of 80 patients with Total IgG deficiency can be divided according to the medical history into three clinical subgroups: recurrent respiratory tract infections (RRT), primary immunodeficiency (PID) and transient hypogammaglobulinemia of infancy (THI). Analyzing IgG abnormality groups, it was concluded that for the population with IgG greater than IgG sum, there is a lower proportion of patients with IgG below normal range than with IgG normal or above normal range.
The authors concluded that determination of serum immunoglobulin levels is an increasingly available and relatively inexpensive laboratory test performed not only in specialized departments but also in primary care. Assessment of IgG levels as well as IgA and IgM is one of the fundamental studies on the function of the immune system. The indications for their markings are very different and primarily include diagnostics for primary and secondary immunodeficiencies. The study was published on June 27, 2018, in the journal BMC Immunology.
Related Links:
Wroclaw Medical University
Latest Clinical Chem. News
- New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
- Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
- Study Compares Analytical Performance of Quantitative Hepatitis B Surface Antigen Assays
- Blood Test Could Predict and Identify Early Relapses in Myeloma Patients
- Compact Raman Imaging System Detects Subtle Tumor Signals
- Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics
- POC Breath Diagnostic System to Detect Pneumonia-Causing Pathogens
- Online Tool Detects Drug Exposure Directly from Patient Samples
- Chemical Imaging Probe Could Track and Treat Prostate Cancer
- Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
- VOCs Show Promise for Early Multi-Cancer Detection
- Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
- Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
- Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
- Simple Non-Invasive Hair-Based Test Could Speed ALS Diagnosis
- Paper Strip Saliva Test Detects Elevated Uric Acid Levels Without Blood Draws
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







